HYPERION DEFI, INC. Operating Income
HYPERION DEFI, INC. (HYPD) reported Operating Income of $31.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- HYPERION DEFI, INC. operating income (loss) for the quarter ending 2026-06-30 was $31.01M.
- HYPERION DEFI, INC. operating income (loss) for the quarter ending 2026-03-31 was $8.73M.
- HYPERION DEFI, INC. operating income (loss) for the quarter ending 2025-12-31 was -$39.77M.
- HYPERION DEFI, INC. operating income (loss) for the quarter ending 2025-09-30 was $4.43M.
- HYPERION DEFI, INC. operating income (loss) for fiscal 2025 was -$46.72M.
- HYPERION DEFI, INC. operating income (loss) for fiscal 2024 was -$48.74M.
- HYPERION DEFI, INC. operating income (loss) for fiscal 2023 was -$25.41M.
- HYPERION DEFI, INC. operating income (loss) for fiscal 2022 was -$26.91M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $31.01M 10-Q · filed 2026-08-13 | $39.74M 10-Q · filed 2026-08-13 | -$25.42K derived: sum of 3 quarters · filed 2026-08-13 | $4.40M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $8.73M 10-Q · filed 2026-05-15 | -$31.03M derived: sum of 2 quarters · filed 2026-05-15 | -$26.60M derived: sum of 3 quarters · filed 2026-05-15 | -$34.96M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$39.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$35.34M derived: sum of 2 quarters · filed 2026-03-30 | -$43.69M derived: sum of 3 quarters · filed 2026-08-13 | -$46.72M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $4.43M 10-Q · filed 2025-11-14 | -$3.93M derived: sum of 2 quarters · filed 2026-08-13 | -$6.96M 10-Q · filed 2025-11-14 | -$26.41M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$8.35M 10-Q · filed 2026-08-13 | -$11.38M 10-Q · filed 2026-08-13 | -$30.84M derived: sum of 3 quarters · filed 2026-08-13 | -$38.17M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$3.03M 10-Q · filed 2026-05-15 | -$22.48M derived: sum of 2 quarters · filed 2026-05-15 | -$29.81M derived: sum of 3 quarters · filed 2026-05-15 | -$41.50M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$19.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$26.78M derived: sum of 2 quarters · filed 2026-03-30 | -$38.47M derived: sum of 3 quarters · filed 2026-03-30 | -$48.74M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$7.33M 10-Q · filed 2025-11-14 | -$19.02M derived: sum of 2 quarters · filed 2025-11-14 | -$29.29M 10-Q · filed 2025-11-14 | -$36.75M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | -$11.69M 10-Q · filed 2025-08-13 | -$21.96M 10-Q · filed 2025-08-13 | -$29.42M derived: sum of 3 quarters · filed 2025-08-13 | -$35.94M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$10.27M 10-Q · filed 2025-05-19 | -$17.73M derived: sum of 2 quarters · filed 2025-05-19 | -$24.25M derived: sum of 3 quarters · filed 2025-05-19 | -$30.21M derived: sum of 4 quarters · filed 2025-05-19 | ||||
| 2023-12-31 | -$7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$13.99M derived: sum of 2 quarters · filed 2025-04-15 | -$19.95M derived: sum of 3 quarters · filed 2025-04-15 | -$25.41M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | -$6.52M 10-Q · filed 2024-11-12 | -$12.48M derived: sum of 2 quarters · filed 2024-11-12 | -$17.94M 10-Q · filed 2024-11-12 | -$23.31M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$5.96M 10-Q · filed 2024-08-14 | -$11.42M 10-Q · filed 2024-08-14 | -$16.79M derived: sum of 3 quarters · filed 2024-08-14 | -$24.02M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$5.46M 10-Q · filed 2024-05-15 | -$10.83M derived: sum of 2 quarters · filed 2024-05-15 | -$18.06M derived: sum of 3 quarters · filed 2024-05-15 | -$25.18M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$12.60M derived: sum of 2 quarters · filed 2024-03-18 | -$19.72M derived: sum of 3 quarters · filed 2024-03-18 | -$26.91M 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | -$7.23M 10-Q · filed 2023-11-13 | -$14.35M derived: sum of 2 quarters · filed 2023-11-13 | -$21.54M 10-Q · filed 2023-11-13 | -$18.49M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$7.12M 10-Q · filed 2023-08-11 | -$14.31M 10-Q · filed 2023-08-11 | -$11.26M derived: sum of 3 quarters · filed 2023-08-11 | -$17.18M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$7.19M 10-Q · filed 2023-05-12 | -$4.13M derived: sum of 2 quarters · filed 2023-05-12 | -$10.06M derived: sum of 3 quarters · filed 2023-05-12 | -$14.84M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$2.87M derived: sum of 2 quarters · filed 2023-03-31 | -$7.65M derived: sum of 3 quarters · filed 2023-03-31 | -$13.02M 10-K · filed 2023-03-31 | -$12.90M 10-K · filed 2022-03-30 | |||
| 2021-09-30 | -$5.93M 10-Q · filed 2022-11-14 | -$5.91M 10-Q · filed 2021-11-12 | -$10.71M derived: sum of 2 quarters · filed 2022-11-14 | -$16.07M 10-Q · filed 2022-11-14 | -$16.02M 10-Q · filed 2021-11-12 | -$20.28M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$4.78M 10-Q · filed 2022-08-11 | -$4.76M 10-Q · filed 2021-08-12 | -$10.15M 10-Q · filed 2022-08-11 | -$10.11M 10-Q · filed 2021-08-12 | -$14.36M derived: sum of 3 quarters · filed 2022-08-11 | -$19.45M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$5.37M 10-Q · filed 2022-05-13 | -$5.35M 10-Q · filed 2021-05-14 | -$9.57M derived: sum of 2 quarters · filed 2022-05-13 | -$14.67M derived: sum of 3 quarters · filed 2022-05-13 | -$19.68M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$9.30M derived: sum of 2 quarters · filed 2022-03-30 | -$14.32M derived: sum of 3 quarters · filed 2022-03-30 | -$19.79M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | -$5.09M 10-Q · filed 2021-11-12 | -$10.11M derived: sum of 2 quarters · filed 2021-11-12 | -$15.58M 10-Q · filed 2021-11-12 | -$20.87M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$5.02M 10-Q · filed 2021-08-12 | -$10.49M 10-Q · filed 2021-08-12 | -$15.78M derived: sum of 3 quarters · filed 2021-08-12 | -$20.47M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$5.47M 10-Q · filed 2021-05-14 | -$10.76M derived: sum of 2 quarters · filed 2021-05-14 | -$15.45M derived: sum of 3 quarters · filed 2021-05-14 | -$20.83M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$9.98M derived: sum of 2 quarters · filed 2021-03-30 | -$15.36M derived: sum of 3 quarters · filed 2021-03-30 | -$21.31M 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | -$4.69M 10-Q · filed 2020-11-12 | -$10.07M derived: sum of 2 quarters · filed 2020-11-12 | -$16.02M 10-Q · filed 2020-11-12 | -$22.20M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$5.38M 10-Q · filed 2020-08-14 | -$11.33M 10-Q · filed 2020-08-14 | -$17.51M derived: sum of 3 quarters · filed 2020-08-14 | -$21.83M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$5.95M 10-Q · filed 2020-05-14 | -$12.14M derived: sum of 2 quarters · filed 2020-05-14 | -$16.46M derived: sum of 3 quarters · filed 2020-05-14 | -$19.78M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$10.50M derived: sum of 2 quarters · filed 2020-03-30 | -$13.82M derived: sum of 3 quarters · filed 2020-03-30 | -$17.26M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$4.32M 10-Q · filed 2019-11-13 | -$7.64M derived: sum of 2 quarters · filed 2019-11-13 | -$11.07M 10-Q · filed 2019-11-13 | -$13.24M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$3.32M 10-Q · filed 2019-08-13 | -$6.75M 10-Q · filed 2019-08-13 | -$8.92M derived: sum of 3 quarters · filed 2019-08-13 | -$9.80M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$3.43M 10-Q · filed 2019-05-14 | -$5.60M derived: sum of 2 quarters · filed 2019-05-14 | -$6.48M derived: sum of 3 quarters · filed 2019-05-14 | -$7.46M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | -$3.05M derived: sum of 2 quarters · filed 2019-03-27 | -$4.03M derived: sum of 3 quarters · filed 2019-03-27 | -$5.13M 10-K · filed 2019-03-27 | ||||
| 2017-09-30 | -$885.28K 10-Q · filed 2018-11-13 | -$1.86M derived: sum of 2 quarters · filed 2018-11-13 | -$2.97M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | -$976.88K 10-Q · filed 2018-08-14 | -$2.08M 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | -$1.11M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | -$3.53M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |